Zhongnan Medical Journal Press

Home Results

A total of 1967 result was found. Results

Data mining for hypertension associated with VEGFR-TKIs: based on FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1201-1208.
6592 times 1550 times

Xiao-Lan LIAO Jia-Qi GE Hai-Bin ZHU Ting-Ting WU Chun-Xia REN Zi-Cheng YU

Vascular endothelial growth factor receptor-tyrosine kinase inhibitors Hypertension Adverse drug events Pharmacovigilance FAERS database
Details
Poly ADP-ribose polymerase inhibitor-induced thrombocytopenia: recent advances in pathogenesis and treatments

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1209-1216.
6183 times 1434 times

Ying-Chen ZHUO Su-Ya ZHANG Peng-Fei SONG Wei-Yi FENG

Poly ADP-ribose polymerase inhibitor Thrombocytopenia Ovarian cancer Adverse drug reaction
Details
Practice and reflection of pharmacovigilance system construction

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1217-1224.
7905 times 1907 times

Na WANG Kang-Huai ZHANG

Pharmacovigilance Drug use safety Risk prevention and control Adverse drug reaction Medication error
Details
Clinical practice of drug abnormal early warning based on dynamic monitoring of clinical pharmacists

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1225-1230.
6515 times 1621 times

Ting-Ting ZHENG Jin LI Lu MAO Ning CHEN Wei ZHANG Jian-Cun ZHEN

Rational drug use Abnormal early warning Dynamic monitoring Clinical pharmacist
Details
Clinical practice guidelines for the use of intravenous polymyxins in children: a protocol

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1231-1237.
5582 times 1390 times

Lin TANG Shan SHEN Dong-Na ZOU Bing LENG Rui-Fang NIE Yan JIN Li-Kai LIN Xian-Tao ZENG Suo-Di ZHAI Ling-Li ZHANG Ning HOU

Polymyxins Pediatric medication Anti-infection Guideline protocol
Details
A retrospective study on the safety of off-indication use of pyrotinib in patients with non-small cell lung cancer

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1238-1242.
5975 times 1536 times

Hao-Chun TANG Jun MENG Zheng-Zheng XIA Ling-Zhi REN

Non-small cell lung cancer Pyrotinib Adverse drug reaction Safety Off-indication
Details
A retrospective study of potential drug-drug interactions of dabigatran etexilate in a tertiary hospital

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1243-1249.
6220 times 1593 times

An-Hua WEI Wen-Jing LI Yan HUANG

Dabigatran etexilate Potential drug-drug interactions Safety Retrospective study
Details
Cost-effectiveness analysis of abemaciclib plus fulvestrant in the second-line treatment for HR﹢/HER2﹣ advanced breast cancer

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1259-1266.
6009 times 1547 times

Xi ZHAO Xi YAN Ning LI Chun-Xia HOU

Abemaciclib Fulvestrant Hormone receptor-positive breast cancer Markov model Cost-effectiveness analysis
Details
Optimization of extraction process of Coptidis Rhizoma-Scutellariae Radix based on BP-ANN and CCD-RSM in information entropy theory

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1267-1274.
5321 times 1316 times

Bao-Cai WANG Jun-Jiang LI Zhi-Wei XU

Coptidis Rhizoma-Scutellariae Radix BP-ANN CCD-RSM Extraction process Information entropy theory
Details
Treatment strategy selection for T2DM patients poorly treated with basal insulin combined with oral hypoglycemic agents: umbrella review

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1275-1284.
6191 times 1472 times

Ya-Ping NIU San-Bao CHAI Jing-Zi MA Meng ZHANG Zuo-Xiang LIU Shan-Shan WU Feng SUN

Basal insulin Oral hypoglycemic agents Type 2 diabetes mellitus Poor treatment effect Umbrella review
Details
Analysis of clinical features of tacrolimus induced acute pancreatitis based on literature cases

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1285-1295.
5722 times 2013 times

Chao YE Xin LI Li-Hua LIU Xin HE Shen-Jue CHEN Juan WANG

Tacrolimus Acute pancreatitis Case report Adverse drug reactions Literature analysis
Details
National competent authority regulation and practice of drug benefit-risk communication in the United States, European Union and China

Published on Chinese Journal of Pharmacoepidemiology 2024,33(1):19-27.
7335 times 1934 times

ZHANG Yinan WU Tingxi ZHAO Zhigang

Drug benefit-risk communication Safety communication Drug safety information Pharmacovigilance
Details
A case of severe immune-related ulcerative colitis caused by pembrolizumab

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1311-1315.
6825 times 1495 times

Jin-Jin ZOU Ji-Liang ZHANG Ni LI Ding-Yi LIU

Pembrolizumab Lung squamous cell carcinoma Severe immune-related ulcerative colitis Adverse drug reactions
Details
A case of sudden cardio arrest caused by oxaliplatin injection

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1316-1320.
6038 times 1581 times

Ying WANG Qin-Yong SHEN Shan HUANG Bing LIN Ai-Wen HUANG

Oxaliplatin Sudden cardio arrest Allergic reaction Adverse drug reaction
Details
Pharmaceutical practice of clinical pharmacists participating in the treatment for refractory edema secondary to diabetic kidney disease

Published on Chinese Journal of Pharmacoepidemiology 2023,32(12):1425-1431.
6885 times 1765 times

Ze CHEN Wei TIAN Qi JIN Xian-Xi GUO Hua HU

Clinical pharmacist Drug treatment Diabetic kidney disease Refractory edema Pharmaceutical care
Details